Find a clinical trial

Search by keyword
Phases
Recruitment Status
Indications
Reset


Dysport in Vulvodynia Phase II Study


Phase: Phase II Trial

Status: Recruiting

Indication: Vulvodynia

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours


Phase: Phase I Trial

Status: Recruiting

Indication: Solid Tumor

Dysport in Post-Surgical Neuralgia


Phase: Phase II Trial

Status: Completed

Indication: Chronic Scar Pain

Dysport in Hallux Abducto Valgus (HAV) Phase IIa


Phase: Phase II Trial

Status: Active, not recruiting

Indication: Hallux Abductovalgus


The list above displays information about clinical trials sponsored by Ipsen.

Only interventional studies that are not yet recruiting, recruiting, active not recruiting or completed since 2015 will be displayed.

The study results will be available on clintrial.gov from 12 months after the end of the study.

To learn more about available studies, go on: https://clinicaltrials.gov/.

Last updated date: 07/30/2020


© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020